Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,871 | 41,002 | 23,895 | 21,155 | 23,262 |
| Marketable Securities | 206,290 | 214,871 | 250,408 | 200,359 | 199,083 |
| Receivables | 15,427 | 18,510 | 14,955 | 16,566 | 13,400 |
| Inventories | 4,751 | 2,826 | 3,253 | 2,713 | 3,230 |
| Other current assets | 47,173 | 46,849 | 46,526 | 47,500 | 47,173 |
| TOTAL | $322,398 | $332,352 | $342,590 | $300,157 | $297,739 |
| Non-Current Assets | |||||
| PPE Net | 2,428 | 2,587 | 382 | 381 | 417 |
| Intangibles | 181,894 | 182,979 | 184,234 | 185,368 | 161,196 |
| Other Non-Current Assets | 3,661 | 7,364 | 5,214 | 48,065 | 47,748 |
| TOTAL | $187,983 | $192,930 | $189,830 | $233,814 | $209,361 |
| Total Assets | $510,381 | $525,282 | $532,420 | $533,971 | $507,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,671 | 7,522 | 3,066 | 6,285 | 4,647 |
| Accrued Expenses | 30,192 | 33,308 | 40,376 | 23,159 | 20,392 |
| Other current liabilities | 41,692 | 42,432 | 38,673 | 50,624 | 41,578 |
| TOTAL | $76,555 | $83,262 | $85,994 | $80,068 | $66,617 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 128,530 | 127,828 | 130,369 | 127,428 | 101,933 |
| TOTAL | $132,891 | $134,253 | $138,831 | $139,531 | $121,251 |
| Total Liabilities | $209,446 | $217,515 | $224,825 | $219,599 | $187,868 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,173 | 38,094 | 37,732 | 36,731 | 36,677 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -129,014 | -113,056 | -104,453 | -67,340 | -53,937 |
| Other shareholders' equity | -421 | -490 | -304 | 21 | -162 |
| TOTAL | $300,935 | $307,767 | $307,595 | $314,372 | $319,232 |
| Total Liabilities And Equity | $510,381 | $525,282 | $532,420 | $533,971 | $507,100 |